bioRxivMicrobiology
Non-permissive human conventional CD1c+ dendritic cells enable trans-infection of human primary renal tubular epithelial cells and protect BK polyomavirus from neutralization
M. Sikorski, F. Coulon, C. Peltier, C. Braudeau, A. Garcia, M. Giraud, K. Autain-Renaudin, C. Kandel-Aznar, S. Nedellec, P. Hulin, J. Branchereau, J. Veziers, P. Gaboriaud, A. Touze, J. Burlaud-Gaillard, R. Josien, D. McIlroy, C. Bressollette-Bodin, F. Halary
Abstract
The BK polyomavirus (BKPyV) is a ubiquitous human virus that persists in the renourinary epithelium. Immunosuppression can lead to BKPyV reactivation in the first year post-transplantation in kidney (KTR) and hematopoietic stem cell transplant recipients. In KTR, persistent DNAemia has been correlated to the occurrence of polyomavirus-associated nephropathy (PVAN) that can lead to graft loss if not properly controlled. Based on recent observations that conventional dendritic cells (cDC) specifically infiltrate PVAN lesions, we hypothesized that those cells could play a role in BKPyV infection. We first demonstrated that monocyte-derived DC (MDDC), an in vitro model for mDC, captured BKPyV particles through an unconventional GRAF-1 endocytic pathway. Neither BKPyV particles nor BKPyV-infected cells were shown to activate MDDC. Endocytosed virions were efficiently transmitted to permissive cells and shown to be protected from the antibody-mediated neutralization. Finally, we demonstrated that freshly isolated CD1c+ mDC from the blood and kidney parenchyma behaved similarly to MDDC thus extending our results to cells of clinical relevance. This study sheds light on a potential unprecedented CD1c+ mDC involvement in the BKPyV infection as a promoter of viral spreading.
- organism: human
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- research focus: cell-cell communication
- research focus: variant calling
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Highly Potent Human Antibody Neutralizing All Serotypes of BK Polyomavirus
Marcel Weber, Simone Schmitt, … Matthias Hillenbrand·PLoS PathogensPeer-reviewed·Jul 18, 2025
- A Cell Culture Model of BK Polyomavirus Persistence, Genome Recombination, and Reactivation
M. Imperiale, L. Zhao·bioRxiv·Aug 5, 2021
- BK polyomavirus evades innate immune sensing by disrupting the mitochondrial network and membrane potential and by promoting mitophagy
J. Manzetti, F. H. Weissbach, … H. H. Hirsch·bioRxiv·Mar 19, 2020
- BKV clearance time correlates with exhaustion state and T-cell receptor repertoire shape of BKV-specific T-cells in renal transplant patients
U. Stervbo, M. Nienen, … N. Babel·bioRxiv·Feb 21, 2019
- The change of lymphocyte subsets and inflammatory cytokine in BK viruria
- OFF-Target Effects of Mycophenolic Acid on BK Polyomavirus Replication in Primary Human Renal Proximal Tubular Epithelial Cells
Caroline A. Hillenbrand, Dorssa Akbari Bani, … Hans Hellmuth Hirsch·bioRxiv·Jan 21, 2026